Copyright: ©Author(s) 2026.
World J Clin Cases. May 16, 2026; 14(14): 118964
Published online May 16, 2026. doi: 10.12998/wjcc.v14.i14.118964
Published online May 16, 2026. doi: 10.12998/wjcc.v14.i14.118964
Table 1 Basic characteristics of the included studies
| Ref. | Hernia | Reason for ICG administration | Dosage of ICG administration | Details of ICG administration (timings) | Outcomes |
| Zhang et al[9], 2024 | Inguinal | Perfusion/viability assessment; lymphatic mapping; vascular anatomy/avoid injury; anatomical delineation | 25 mg ICG diluted in 10 mL saline | Intraoperative; Intraoperatively; following this; following inguinal | Feasible/helpful; guided decisions/avoided injury or resection; complications reported/assessed |
| Nakaseko et al[10], 2023 | Inguinal | Lymphatic mapping; vascular anatomy/avoid injury | 0.25 mg; 2.5 mg; 0.25 mg | Intraoperative; following open; following endoscopic | Feasible/helpful; guided decisions/avoided injury or resection; complications reported/assessed |
| Nakashima et al[11], 2022 | Inguinal | Perfusion/viability assessment; vascular anatomy/avoid injury | 5 mg; 0.63 mg; 34.1 mg | Intraoperative; intraoperative | Feasible/helpful; guided decisions/avoided injury or resection; complications reported/assessed; no ICG-related adverse events |
| Ryu et al[12], 2016 | Inguinal | Perfusion/viability assessment; vascular anatomy/avoid injury | 5 mg | Intraoperative; intraoperative | Feasible/helpful; guided decisions/avoided injury or resection |
| Aarsh et al[13], 2024 | Inguinal | Perfusion/viability assessment; vascular anatomy/avoid injury; anatomical delineation | NR | Intraoperative | Feasible/helpful; guided decisions/avoided injury or resection; complications reported/assessed |
| Shimada et al[14], 2022 | Inguinal | Perfusion/viability assessment; lymphatic mapping; vascular anatomy/avoid injury; anatomical delineation | 2.5 mg; 5 mg; 0.25 mg | Intraoperative; intraoperative; intra-operative; prior to laparoscopic | Feasible/helpful; guided decisions/avoided injury or resection; complications reported/assessed; no ICG-related adverse events |
| Daskalopoulou et al[15], 2018 | Inguinal | Perfusion/viability assessment; lymphatic mapping; anatomical delineation | NR | Intraoperative; intraoperative; following hernia; following injection | Feasible/helpful; guided decisions/avoided injury or resection; complications reported/assessed; no ICG-related adverse events |
| Nakaseko et al[16], 2023 | Inguinal | Perfusion/viability assessment; lymphatic mapping; vascular anatomy/avoid injury; anatomical delineation | NR | Intra-operative; intra-operative; intra-operatively; prior to surgery | Feasible/helpful; guided decisions/avoided injury or resection; complications reported/assessed; no ICG-related adverse events |
| Todeschini et al[17], 2024 | Inguinal | Vascular anatomy visualization; prevention of iatrogenic vascular injury; anatomical delineation | NR | Intravenous; intraoperative; before peritoneal dissection; repeated before mesh fixation | Feasible/helpful; clear visualization of iliac and spermatic vessels within 45 seconds; guided surgical decisions; no complications reported |
| Yodying[18], 2024 | Left paraduodenal hernia (strangulated) | Bowel perfusion intra-operatively to guide resection decision | NR | Intraoperative | Guided decision on bowel resection, laparoscopic repair achieved despite challenging presentation, no ICG-related adverse events reported |
| Wormer et al[19], 2016 | Complex abdominal wall reconstruction | Assess tissue perfusion to reduce wound complications | NR | ICG-FA performed after repair and before flap closure; surgeons blinded vs non-blinded to imaging | ICG-FA identified hypoperfused areas; modification did not significantly reduce wound complications (15.6% vs 12.5%) |
| Ahmed et al[20], 2022 | Mixed surgical cases, including hernia repairs | Assess vascularity, bowel viability, lymphatic mapping, and flap vascularity | NR | Intraoperatively | Feasible across procedures; potential for improved anatomic/vascular assessment; hernia-specific outcomes not separately reported |
| Tsuchiya et al[21], 2022 | Hernia | Intestinal perfusion assessment: Evaluation of bowel and mesenteric blood flow | NR | Intraoperative; intravenous; during laparoscopic parastomal hernia repair | Feasible/helpful; confirmed adequate intestinal perfusion; guided safe repair; no postoperative complications; no recurrence at 6 months |
| Glanzer et al[22], 2021 | Hernia | Identification and protection of ureters | NR | Intraoperatively, intraurethral injection | Feasible/helpful; guided decisions/avoided injury |
| Kozadinos et al[23], 2021 | Hernia | Perfusion/viability assessment | NR | Intraoperatively; IV | Feasible/helpful; guided decisions/avoided resection (excellent perfusion, no resection needed) |
| Colavita et al[24], 2016 | Hernia | Perfusion mapping to predict wound complications | 0.25 mg | Intraoperatively, IV; performed twice: Prior to incision and prior to closure | Strong predictor of wound complications; significant association between poor perfusion and complications |
| Cengiz et al[25], 2017 | Hernia | Perfusion/viability assessment | 5 mg | Intraoperatively; IV | Feasible/helpful; guided decisions/avoided resection |
- Citation: Pavlidis L, Geropoulos G, Kechagias KS, Psarras K, Patel V, Reza L, Prakash N, Athanasiou C, Geropoulos V, Anestiadou E, Triantafyllou T, Sapalidis K, Laskou S, Dimitroulis D. Near-infrared fluorescence with indocyanine green for minimally invasive hernia surgery: A systematic review and evidence synthesis. World J Clin Cases 2026; 14(14): 118964
- URL: https://www.wjgnet.com/2307-8960/full/v14/i14/118964.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v14.i14.118964